Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter

Takaaki Miyaji, Tatsuya Kawasaki, Natsuko Togawa, Hiroshi Omote, Yoshinori Moriyama

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

SLC17A1 protein (NPT1) was the first identified member of the SLC17 phosphate transporter family, and is known to mediate Na+/inorganic phosphate (Pi) co-transport when expressed in Xenopus oocytes. Although this protein was suggested to be a renal polyspecific anion exporter, its transport properties were not well characterized. The clean biochemical approach revealed that proteoliposomes comprising purified NPT1 as the only protein source transport various organic anions such as urate, p-aminohippuric acid (PAH), and acetylsalicylic acid (aspirin) in a membrane potential (δ̄)-driven and Cl- -dependent manner. Human NPT1 carrying an SNP mutation, Thr269Ile, known to increase the risk of gout, exhibited 32% lower urate transport activity compared to the wild type protein, leading to the conclusion that NPT1 is the long searched for transporter responsible for renal urate excretion. In the present article, we summarized the history of identification of the urate exporter and its possible involvement in the dynamism of urate under physiological and pathological conditions.

Original languageEnglish
Pages (from-to)88-94
Number of pages7
JournalCurrent Molecular Pharmacology
Volume6
Issue number2
DOIs
Publication statusPublished - 2013

Keywords

  • Drug excretion
  • Gout
  • Membrane potential
  • Naspi_sup+spii_sup/inorganic phosphate transporter
  • Non-steroidal anti-inflammatory drug
  • Urate

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter'. Together they form a unique fingerprint.

Cite this